Share of clinical trials for rare diseases in Italy 2013-2018
The statistic shows the share of authorized clinical trials to treat rare diseases in Italy from 2013 to 2018. According to data, the percentage of clinical trials related to rare diseases out of the total number of them authorized by the Italian Drug Agency, increased over the period considered, peaking at 31.5 percent as of 2018.